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Purpose. To compare the ocular surface symptoms and signs in an adult population of silicone-hydrogel (Si-Hy) contact lens
(CL) wearers with another modality of CL wear, overnight orthokeratology (OK). Materials and Methods. This was a prospective
and comparative study in which 31 myopic subjects were fitted with the same Si-Hy CL and 23 underwent OK treatment for 3
months. Dry eye questionnaire (DEQ) was filled in at the beginning of the study and then after 15 days, 1 month, and 3 months
using each CL modality. The tear quality was evaluated with noninvasive tear break-up time. Tear production was measured with
Schirmer test. Tear samples were collectedwith Schirmer strips being frozen to analyze the dinucleotide diadenosine tetraphosphate
(Ap
4
A) concentration with High-Performance Liquid Chromatography (HPLC). Results. After refitting with ortho-k, a reduction
in discomfort and dryness symptoms at the end of the day (𝑝 < 0.05, 𝜒2) was observed. No significant changes were observed in
Ap
4
A concentration in any group. Bulbar redness, limbal redness, and conjunctival staining increased significantly in the Si-Hy
group (𝑝 < 0.05, Kruskal–Wallis test). Conclusion. Discomfort and dryness symptoms at the end of the day are lower in the OK CL
group than in the Si-Hy CL group.
1. Introduction
Nowadays, many people use contact lenses (CLs) and
silicone-hydrogel (Si-Hy) CL in daily wear basis is the most
commonly fitted modality of CL wear around the world [1].
However, soft CL wearers frequently report symptoms of
discomfort and dryness, especially at the end of the day [2–
4]; these symptoms are the most common reason of CL wear
drop-out [5–8]. In the last years, the CL market has changed
significantly with the introduction of new materials, designs,
and care systems. In this regard, the use of silicone-hydrogel
(Si-Hy) CLs may help reduce these symptoms [9, 10], as well
as the use of some lens care solutions [11]. However, despite
the attempts to solve these symptoms, dryness anddiscomfort
remain themost frequent reason for CLwear discontinuation
[5–8]. The prevalence of dryness and discomfort among soft
CL wearers is higher than that in no CL wearers [7, 12, 13],
having been estimated to be 50% [13–17]. In fact, dry eye
(DE) related to CL wear has been included as a subtype of
evaporative DE in the International Dry Eye Workshop in
2007 [18].
As it is seems clear that wearing soft CLs induces dryness
and discomfort symptoms, avoiding CL wear during the
day could be a good option in subjects who suffer from
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these symptoms. In this regard, orthokeratology (OK) is a
technique used to reduce the refractive error temporarily.
The refraction change is obtained by the programmed appli-
cation of specially designed rigid gas permeable CLs [19]. In
myopic patients, this procedure induces epithelial thinning
of the central cornea and thickening in the mid-peripheral
cornea, leading to a myopia reduction and improved unaided
vision [20, 21]. With hyperpermeable lens materials, the OK
CLs are worn during the night, while the subject is sleeping.
Therefore, the subject has a good vision during the waking
hours without using any type of CLs or spectacles.
Hence, the purpose of this study was to characterize and
to compare the ocular surface symptoms using the dry eye
questionnaire (DEQ) between two different modalities of CL
wear. One group wore Si-Hy CLs and another one underwent
OK treatment for three months.
On the other hand, some studies have shown poor
correlation between the DE signs and symptoms [22, 23], so
it is important to find objective biomarkers to help in the
DE diagnoses. Previous studies have shown that several in-
flammatory cytokines show increased levels in DE patients
[24–28]. Other relevant molecules are dinucleotides and
Jesus Pintor Research Group found the presence of diade-
nosine polyphosphates in the tear film in 2002 [29]. The
researchers also observed that the dinucleotide diadenosine
tetraphosphate (Ap
4
A) concentration rises in patients with
DE symptoms, with either normal or low tear production
[30, 31], suggesting the possibility that this molecule could
be an objective parameter for grading DE. Therefore, in
collaboration with this group, a pilot study was performed
comparing the subjective symptoms evaluated with the DEQ
with the changes in Ap
4
A concentration in a small group of
participants.
2. Materials and Methods
Thiswas a prospective, nonrandomized, comparative study in
which the ocular surface signs and symptoms were compared
between a group fitted with a Si-Hy CL in daily wear basis
and another one that underwent overnight OK treatment
for 3 months. All participants were recruited at the Clinical
and Experimental Optometry Research Lab (CEORLab) at
the University of Minho (Portugal), with the sample being
composed by staff and students from theUniversity ofMinho.
All procedures conformed to the tenets of the Declaration of
Helsinki. The Ethics Committee of the School of Sciences of
the University of Minho (CEECUM) approved the study, and
informed consent was obtained from each individual prior to
the initiation of the study. All the participants had to satisfy
the following inclusion and exclusion criteria (Table 1) to be
eligible for the study.
At an initial visit, a comprehensive optometric examina-
tion has been done including determination of the refraction,
visual acuity, and appropriateness to use contact lenses, and
meeting the inclusion criteria. When necessary, an ophthal-
mologist evaluated the patient to establish whether he/she
was appropriate candidate for contact lens wear. After that, 31
subjects were fitted with Si-Hy CL and 26 with OK CL, being
the participants allocated in each group depending on the
Table 1: Inclusion and exclusion criteria of the present study.
Inclusion criteria Exclusion criteria
18 to 35 years of age
Absence of ocular diseases
including DE
Flat keratometry between 40.0
and 45.0D
Refractive sphere between
−1.00 and −6.00D
Able to understand and sign
the consent form and to
attend the scheduled visits
Not able to attend visits
Symptomatic CL wearer
Taking topical or systemic
medication
Astigmatism ≥ 1.00D in the
Si-Hy group and ≥1.75D in the
OK group
Other clinically significant
ocular findings compatible with
inflammation
History of ocular surgery
personal preferences and taking into account whether their
ocular parameters allowed correcting the fullmyopiawith the
OK treatment or did not. Three participants in the OK group
left the study during the first week of the OK treatment, so,
for the statistical analysis, 31 Si-Hy CL wearers (6 men and 25
women) and 23 OK CL wearers (7 men and 16 women), who
attended at least 1-month visit, were included.
All of the participants in the Si-Hy group were soft
CL wearers but in the OK group 16 were soft CL wearers
and 7 had not worn any type of CL before the study. All
the participants were Caucasian and the characteristics of
age, spherical equivalent (SE) refraction, visual acuity (VA),
and corneal curvature are summarized in Table 2, with no
statistically significant differences between both groups for
any of these parameters.
The participants who were CL wearers were asked to
discontinue their CL wear for 1 week before attending the
baseline visit. Then, the scheduled visits were at 15 days and
1 month in the morning and at 3 months in the morning and
afternoon for both groups. The participants were evaluated
during the morning, maximum two hours after awaking,
except for the 3-month afternoon visit, which was conducted
at least 6 hours after themorning visit. In theOK group,more
visits were scheduled at the beginning of the study to control
the evolution of the OK treatment.
2.1. Contact Lenses (CLs). The Si-Hy CL used was Biofinity5
(Comfilcon A, 48% water content, CooperVision) in daily
wear basis and was replaced monthly. The maintenance
solutions used were the following multipurpose disinfecting
solutions (MPDSs): Synergi5 (Sauflon, UK), COMPLETE5
RevitaLens (Abbott Medical Optics, Santa Ana, CA), and
OPTI-FREE5 PureMoist5 (Alcon, Fort Worth, TX). All of
them include components to enhance the comfort of the CLs.
TheOKCL used was Corneal RefractiveTherapy5 (Paflu-
con D, Paragon CRT5). Paragon CRT Dual Axis was used
in subjects with limbus-to-limbus corneal astigmatism. The
initial CLswere fitted following themonograms of adaptation
of the CRT manufacturer. If needed, some CL parameters
were changed to obtain a full correction of the myopic
refraction and, at the same time, a well centered CL. These
CLs are replaced yearly, so if the first CL fit was successful, the
participants used the same CLs during the 3 months. These
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Table 2: Characteristics of the participants in the study.
CL Baseline
Age (years)
Si-Hy 22.97 ± 4.17
OK 22.00 ± 2.45
𝑝 0.68b
SE refraction OS (D)
Si-Hy −2.91 ± 1.31
OK −2.89 ± 1.17
𝑝 0.93b
K-flat OS (D)
Si-Hy 43.45 ± 1.25
OK 43.45 ± 1.24
𝑝 0.99a
Monocular VA OS (LogMAR)
Si-Hy −0.08 ± 0.06
OK −0.07 ± 0.06
𝑝 0.44a
Binocular VA (LogMAR)
Si-Hy −0.15 ± 0.13
OK −0.13 ± 0.05
𝑝 0.52a
a
𝑡-test independent; bMann–Whitney test; SE: spherical equivalent; OS: left
eye; VA: visual acuity.
CLs were used during the night, while the CL wearers were
sleeping. The maintenance solution used was peroxide with
saline solution to rinse the CLs before insertion. Moreover,
they were instructed to use free preservative artificial tears
to fill the CLs before being inserted in the eyes and to put
a couple of drops in the eyes when they woke up, before
removing their CLs, to avoid ocular surface damage when the
patients removed the CLs.
2.2. Tests Performed. Figure 1 shows the order in which the
tests were performed. After removing the CLs, the partici-
pants of the Si-Hy group waited 10 minutes before starting
to perform the tests. Between each test, all the participants
were asked to blink normally for at least 1 minute to recover
the tear film stability.
2.3. Visual Acuity (VA). The baseline VA was taken with the
best spectacle correction and the VA in the follow-up visits
was takenwith CLs in the Si-Hy group andwithout CLs in the
OK group. The VA was always measured with high contrast
transilluminated ETDRS test under mesopic conditions.
2.4. Dry Eye Questionnaire (DEQ). The long version of
DEQ was used to evaluate the symptoms [15]. The DEQ
contains questions about 8 symptoms: discomfort, dryness,
sand sensation, burning sensation, itching, foreign body sen-
sation, irritated eyes, and light sensitivity. For each symptom,
frequency, morning and evening intensity, and how much
the symptom bothers the subject are specified. For each
question, the participants had five possible answers from 0
to 4. Regarding frequency, 0 means “never” and 4 means
“constantly,” regarding intensity 0 means “nothing” and 4
means “very intensive,” and regarding bothersomeness 0
means “nothing” and 4 means “a lot.”
Tests performed
OK
Both groups 
of CLs
Si-Hy
VA with CLs VA with CLs +
remove CLs
DEQ
NIBUT + 
topography
Schirmer 
test
Slit lamp 
examination
BUT
Figure 1: Order in which the tests were performed.
Although there is a new version of questionnaire available
to use in CL wearers called Contact Lens Dry Eye Question-
naire (CLDEQ) [32], DEQwas used because it is not expected
that the members of the OK group had symptoms, while they
wore their CLs. Hence, all the participants answered the DEQ
referring their symptoms during the day: in the Si-Hy group
the symptoms happened while the subjects wore their CLs,
and in the OK group the symptoms happened while they did
not.TheDEQwas always answered during themorning visits.
As the Si-Hy group did not have any visit programmed after 15
days, the participants were asked to answer the DEQ at home
and bring the questionnaire in the 1-month visit.
2.5. Tear Evaluation and Tear Collection. Tear quality was
evaluated with noninvasive tear break-up time (NIBUT),
using the Medmont topographer, and with the tear break-up
time (BUT), using the slit lamp biomicroscopy, after instilling
sodium fluorescein (NaFL) with a prepared strip of NaFL
(BioGlo Fluorescein Strips) wetted with a drop of saline
solution. A yellow barrier filter (Wratten #12) was used to
enhance the contrast. Both tests were assessed after asking the
subjects to blink a couple times and the measurements were
performed three times to obtain a more reliable value.
Schirmer test was used to measure the tear production.
A TearFlo Schirmer strip (HUB Pharmaceuticals, USA) was
placed in the temporal lower conjunctival sac of the OS and
then the subjects were asked to keep their eyes closed for 5
minutes. The volume of tear was measured with the inked
ruler of the Schirmer strip.
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For the analysis of Ap
4
A concentration in the tears, the
Schirmer strip used to measure the tear production was
placed in 1.5mL Eppendorf tube containing 500𝜇L of ultra-
pure water. The samples were frozen until the high-pressure
liquid chromatography (HPLC) analysis was performed. The
method followed for Tear Preparation and HPLC Analysis
was previously described byCarracedo et al. [33].The samples
analyzed were taken from 6 OK CL wearers and 5 Si-Hy CL
wearers during the morning visits at baseline and at 3-month
visits.
The normal tear volume is around 6𝜇L and themean tear
secretion rate is 1.2 𝜇L per minute [34]. Therefore, at least 10-
minute period was allowed since finishing the Schirmer test
and before starting to measure the BUT. The ocular surface
may not be totally restored from the Schirmer test after 10
minutes, so, to avoid differences between both groups, the test
order was always the same.
2.6. Slit Lamp Evaluation. The ocular surface was examined
using the slit lamp. To evaluate the conjunctival staining,
bulbar, limbal, and lid redness, and tarsal roughness, the
values were recorded according to the CCLRU grading scales
[35]. The CCLRU scale has four images for each condition
which increase in severity from 1, which means “very slight,”
to 4, which means “severe.”
2.7. Statistical Analysis. Thestatistical analysis was conducted
using SPSS v.21 (SPSS Inc., Chicago, IL, USA). Shapiro–Wilk
test was used to evaluate the data distribution. Statistical
significance was set at the level of 𝑝 = 0.05 and the sample
size was estimated for an 80% statistical power to detect
differences of 1 score in the DEQ.
Chi-square (𝜒2) test was used to evaluate the DEQ scores.
ANOVA or Kruskal–Wallis tests were used to evaluate dif-
ferences among all visits in the same group for the tear
and ocular parameters, as well as VA. Bonferroni post hoc
correction was used as post hoc correction. Independent
sample t-test or Mann–Whitney test was used to evaluate
differences between both groups of CLs in each visit.The tests
used were chosen according to the data distribution. To avoid
the duplication of the sample resulting from the interaction
between both eyes from the same patient, only the left eye
from each patient was used for statistical analysis.
Ap
4
A concentration was analyzed with nonparametric
tests. Mann–Whitney test was used to detect differences
between both groups and Wilcoxon test was used to analyze
differences between baseline and 3-month visit in the same
group.
3. Results
Three participants in the OK group discontinued during the
first week of the OK treatment: two participants discontinued
because they were not able to attend the scheduled visits
and one case of discontinuation was due to a CL dislocation
during the second night of OK CLs wear. The problem
was solved successfully, without any impact on vision or
corneal integrity. Furthermore, one subject from the OK
group left the study after 1 month because her vision was
not stable. There was one case of discontinuation during
the third month in the Si-Hy group because one subject felt
disappointed after breaking 2 CLs with the case of Synergi
solution.
Regarding DEQ, no statistically significant differences
between both groupswere found at baseline for any symptom.
With the use of the CLs, statistically significant differences
were found only for discomfort and dryness. As Table 3
shows, discomfort and dryness symptoms at the end of the
day were lower with the OK treatment, with the difference
between both groups being statistically significant at 15 days
for dryness and at 1 month for discomfort. The differences
between both groups were maintained until the end of the
study. Apart from the differences observed at the end of the
day, statistically significant differences between both groups
were found for frequency of dryness at 15 days and for
bothersomeness of dryness at 1-month visit, with the DEQ
scores being lower in the OK group. These differences were
not maintained until the end of the study.
On the other hand, although no statistically significant
differences were found between both groups, dryness during
the first two hours of the day and bothersomeness of dryness
improved with the use of Si-Hy CLs, and this change was
statistically significant from baseline to 3-month visit (𝑝 <
0.05, Bonferroni post hoc correction).
Table 4 shows the changes in tear film stability and tear
production for each group. There were no statistically sig-
nificant differences in the Schirmer values, neither between
both groups nor among the visits in each group of CLs.
NIBUT values were higher in the OK group compared to
Si-Hy group at baseline and continued being slightly higher
during the study. The BUT values were slightly reduced at
the 1-month visit in the Si-Hy but then came back to
baseline values. When the differences from visit to visit were
analyzed with Bonferroni post hoc correction, no statistically
significant differences were found for BUT values, but a
significant improvement from 1-month visit to 3-month visit
was observed for NIBUT in the Si-Hy group.
Table 5 shows the slit lamp observations in both groups
of CLs. Conjunctival staining, bulbar redness, and limbal
redness increased with the use of Si-Hy CLs. Conjunctival
staining increases significantly from visit to visit, with the
highest values being observed at the 3-month afternoon visit.
Bulbar redness and limbal redness increased significantly
from baseline to the 1-month visit, and limbal redness also
showed a significant increase at the 3-month from morning
to afternoon. However, with the use of the OK CLs, limbal
redness showed a significant reduction, with the differences
between both groups being statistically significant at baseline
and after 3 months of wearing the CLs. Lid roughness was
significantly reduced with the use of the OK CLs, and
the difference between both groups of CLs was statistically
significant at 3-month visit.
Concerning Ap
4
A concentration in tear samples, no
statistically significant differences were found between both
groups, neither at the baseline nor at the 3-month visit (𝑝 >
0.05,U Mann–Whitney test). With the use of the OKCLs, no
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Table 3: Differences in the DEQ scores for each symptom in both groups of CL.
DEQ symptom CL Baseline 15 days 1 month 3 months
Frequency of discomfort
Si-Hy 1.48 ± 0.63 1.39 ± 0.88 1.45 ± 0.77 1.17 ± 0.64
OK 1.09 ± 0.73 1.00 ± 0.77 0.96 ± 0.82 0.91 ± 0.81
𝑝 0.07c 0.53c 0.10c 0.06c
Discomfort during the first 2 hours of the day
Si-Hy 0.84 ± 0.97 1.10 ± 1.04 1.03 ± 0.87 0.73 ± 0.83
OK 0.52 ± 0.59 0.86 ± 0.79 0.74 ± 0.91 0.82 ± 1.14
𝑝 0.17c 0.88c 0.35c 0.24c
Discomfort at the end of the day
Si-Hy 2.06 ± 1.24 1.84 ± 1.32 1.97 ± 1.11 1.67 ± 1.09
OK 1.39 ± 0.99 1.09 ± 1.04 0.96 ± 0.98 0.77 ± 0.92
𝑝 0.24c 0.19c 0.02c 0.02c
Bothersomeness of discomfort
Si-Hy 1.93 ± 0.96 2.10 ± 1.28 1.84 ± 1.04 1.67 ± 1.15
OK 1.30 ± 1.02 1.33 ± 1.11 1.13 ± 0.97 1.00 ± 1.02
𝑝 0.09c 0.05c 0.17c 0.07c
Frequency of dryness
Si-Hy 1.48 ± 0.72 1.61 ± 0.84 1.58 ± 0.81 1.43 ± 0.77
OK 1.22 ± 0.60 1.00 ± 1.00 0.87 ± 0.87 1.27 ± 0.88
𝑝 0.49c 0.02c 0.02c 0.30c
Dryness during the first 2 hours of the day
Si-Hy 1.10 ± 1.01 0.84 ± 1.04 0.87 ± 1.06 0.57 ± 0.63
OK 0.52 ± 0.59 0.76 ± 0.77 0.83 ± 1.27 1.00 ± 1.15
𝑝 0.06c 0.44c 0.30c 0.39c
Dryness at the end of the day
Si-Hy 2.23 ± 1.31 2.16 ± 1.29 2.10 ± 1.16 1.90 ± 1.18
OK 1.61 ± 0.89 0.90 ± 1.04 1.00 ± 1.24 1.14 ± 1.08
𝑝 0.43c 0.01c 0.01c 0.01c
Bothersomeness of dryness
Si-Hy 2.19 ± 1.19 2.23 ± 1.52 2.19 ± 1.17 1.97 ± 1.24
OK 1.56 ± 0.99 1.14 ± 1.15 1.04 ± 1.15 1.27 ± 0.98
𝑝 0.17c 0.16c 0.01c 0.06c
cSignificance for Chi-square test (𝜒2). Bold values in the same group for the same symptom show the visits in which statistically significant differences were
found with Bonferroni post hoc correction.
Table 4: Differences in NIBUT, BUT, and Schirmer tests in both groups of CL. These results are only related to the left eyes.
Tear tests CL Baseline 1-month morning 3-month morning 3-month afternoon 𝑝
NIBUT
Si-Hy 9.03 ± 3.10 7.60 ± 3.42 11.30 ± 6.80 9.60 ± 6.02 0.20∗
OK 15.30 ± 9.01 10.61 ± 8.68 14.23 ± 10.90 12.23 ± 8.97 0.37∗
𝑝 0.01b 0.19b 0.43b 0.23b
BUT
Si-Hy 7.17 ± 3.20 5.68 ± 3.40 7.85 ± 3.62 6.77 ± 2.01 0.03∗
OK 8.74 ± 4.16 8.00 ± 6.26 7.36 ± 4.17 6.82 ± 2.94 0.38∗
𝑝 0.19b 0.05b 0.45b 0.98b
Schirmer
Si-Hy 19.10 ± 11.62 18.93 ± 9.50 21.00 ± 11.79 19.03 ± 11.05 0.81∗
OK 18.26 ± 10.58 21.09 ± 11.44 20.73 ± 11.10 18.32 ± 11.81 0.72∗
𝑝 0.85b 0.32b 0.85b 0.72b
∗Friedman test. bMann–Whitney test. Bold values in the same group for the same symptom show the visits in which statistically significant differences were
found with Bonferroni post hoc correction.
differences were observed, while with the use of Si-Hy CL,
a slight decrease, although not statistically significant, was
found (𝑝 > 0.05, Wilcoxon test).
4. Discussion
Dryness and discomfort symptoms, especially at the end of
the day, are an important problem to solve for CL wearers [3,
4, 36]. In our sample, we observed a reduction in dryness and
discomfort symptoms over time, even in the Si-Hy group.The
deposits accumulated on frequent replacement CLs may lead
to increased dryness and discomfort symptoms. In fact, the
use of daily disposable CLs has been shown to be associated
with enhanced comfort [37–39]. Considering that the CLs
used in the present study are monthly replaced, the potential
impact of deposit build-up on the CLs can be ruled out as a
factor for dryness and discomfort. In a study of Wagner et
al., it was observed that about 14% of subjects replaced their
CLs only when there was a problem, rather than according to
the manufacturer’s recommendations [40]. The fact that we
ensured that all the participants replaced their CLs accurately
each month during the study may be an explanation for the
6 BioMed Research International
Table 5: Slit lamp observations in both groups of CL. These results are only related to the left eyes.
CCLRU signs CL Baseline 1-month morning 3-month morning 3-month afternoon 𝑝
Corneal staining type
Si-Hy 0.47 ± 0.48 0.84 ± 0.82 0.79 ± 0.81 0.66 ± 0.77 0.27∗
OK 0.33 ± 0.49 0.61 ± 0.78 0.64 ± 0.63 0.39 ± 0.53 0.34∗
𝑝 0.26b 0.21b 0.68b 0.22b
Corneal staining depth
Si-Hy 0.48 ± 0.52 0.75 ± 0.72 0.64 ± 0.56 0.54 ± 0.58 0.22∗
OK 0.31 ± 0.46 0.63 ± 0.77 0.62 ± 0.62 0.50 ± 0.58 0.38∗
𝑝 0.23b 0.41b 0.93b 0.74b
Conjunctival staining
Si-Hy 0.21 ± 0.48 0.61 ± 0.71 1.55 ± 0.68 2.28 ± 0.78 <0.01∗
OK 0.96 ± 0.64 0.92 ± 0.53 0.95 ± 0.81 0.95 ± 0.53 1.00∗
𝑝 <0.01b 0.05b 0.01b <0.01b
Bulbar redness
Si-Hy 1.47 ± 0.46 1.98 ± 0.52 1.91 ± 0.39 2.14 ± 0.35 <0.01∗
OK 1.87 ± 0.48 1.67 ± 0.52 1.55 ± 0.40 1.69 ± 0.55 0.19∗
𝑝 0.07b 0.04b <0.01b <0.01b
Limbal redness
Si-Hy 1.39 ± 0.46 1.78 ± 0.53 1.76 ± 0.33 1.95 ± 0.40 <0.01∗
OK 1.66 ± 0.42 1.53 ± 0.49 1.38 ± 0.37 1.37 ± 0.45 0.04∗
𝑝 0.01b 0.10b <0.01b <0.01b
Lid redness
Si-Hy 1.39 ± 0.44 1.46 ± 0.38 1.64 ± 0.36 1.54 ± 0.42 0.05∗
OK 1.67 ± 0.58 1.54 ± 0.51 1.56 ± 0.52 — 0.68∗
𝑝 0.06b 0.66b 0.17b —
Lid roughness
Si-Hy 1.18 ± 0.51 1.06 ± 0.52 1.15 ± 0.56 1.14 ± 0.55 0.71∗
OK 1.40 ± 0.77 1.11 ± 1.04 0.95 ± 1.06 — 0.02∗
𝑝 0.35b 0.54b 0.03b —
∗Kruskal–Wallis test. bMann–Whitney test. Bold values in the same group for the same symptom show the visits in which statistically significant differences
were found with Bonferroni post hoc correction.
improvement in the comfort scores. It may be also possible
that the change of the CLs material or the change in the
MPDS, or a combination of both things, helped improve these
symptoms in the Si-Hy group.
Despite the improvement in the symptoms in both
groups, the results of this study show that discomfort and
dryness symptoms at the end of the day are more reduced
with the use of OK CLs than with the use of Si-Hy CLs.
In this regard, a case report published in 2013 showed that
the OK treatment could be a good option for CL intolerant
patients [41]. In the present study, the values obtained in
the tear parameters do not justify this difference between
both groups, neither the tear quality nor the tear production.
Moreover, no changes in Ap
4
A concentration were observed,
probably due to the small sample size. However, in the Si-
Hy group, the highest scores in the DEQ were found at end
of the day, and the highest values of conjunctival staining,
bulbar redness, and limbal redness were observed at the 3-
month afternoon visit. The increase in bulbar redness and
limbal redness at the end of the day in the Si-Hy group seems
to be related to the presence of the CL on the eye during
several hours, despite the high oxygen permeability of the
CL used. In a previous study, it was seen that the increases
in bulbar redness and limbal redness with the three MPDSs
used in this study were similar, supporting the idea that the
ocular redness is related with the presence of the CL itself
[42]. Moreover, this result agrees with other authors who
observed that the evening peaks of redness coincide with
the peak of CL awareness and dryness symptoms [2–4]. In
addition, it was found that the conjunctival staining increased
significantly in the Si-Hy group, while in the OK group it
was kept constant. The most common type of conjunctival
staining found in the Si-Hy group was a perilimbal staining,
which may reflect an ocular response potentially related with
CL dehydration or mechanical interaction of the CL with the
ocular surface. According to previous studies, conjunctival
staining could be related with the CL geometry, especially
with the edge lens profile, and the material rigidity [43, 44].
In this regard, it has been seen that in DE symptomatic
patients the number ofGoblet cells is reduced [45].These cells
are the principal secretory cells in the conjunctival epithelia
and their main function is to lubricate the ocular surface. It
could be possible that the number of Goblet cells or their
functions are altered during the Si-HyCLwear and thiswould
explain, in part, the higher DEQ scores in the Si-Hy group
compared to the OK group. An additional explanation for
the symptomatology reduction with the OK treatment might
be found in the reduction of corneal sensitivity. This fact has
been reported after one night of OK treatment [46]. If the
corneal sensitivity reduction is maintained while the OK CLs
are worn, this fact could explain in part the reduction in
the dryness and discomfort symptoms. However, this factor
may also be present in the Si-Hy group, since a reduction in
mechanical sensitivity was observed in soft CL wearers at the
end of the day [47]. Furthermore, it has been suggested that a
lower CL dehydration rate might reduce dryness symptoms
[48]. The dehydration rate is influenced by several factors,
such as material features or environmental conditions [49,
50]. In this regard, an “in vitro” study published recently has
BioMed Research International 7
shown that the Si-Hy CL used in this study is quite affected
by the environmental conditions [50]. It could be possible
that, using another Si-Hy CLwith lower dehydration rate, the
symptoms in the Si-Hy group were lower.
On the other hand, lid roughness decreased in the OK
group, which may be related with the no solution delivery
during the day from the OK CLs to the ocular surface.
Moreover, the OK group was using peroxide solution and
previous studies found that lid roughness is reduced with
the use of peroxide, solution without preservatives [51, 52].
In this regard, during the study, both groups used different
cleaning solutions that may have influence on the results
obtained. The participants in the Si-Hy group used MPDSs
that are the most common lens care solution used by soft
CL wearers. However, the OK CLs wearers used peroxide
solution, a very effective disinfecting solution that is rather
important in yearly replacement CLs. The fact that the OK
group used peroxide solution instead of MPDS may help
reduce the symptoms in this group compared to the Si-
Hy group, because a previous study found lower symptoms
with peroxide solution than with MPDSs [53]. An additional
factor that could affect the tarsal response may be the fact
that with Si-Hy CLs the interaction between cornea and
blink physiology is disturbed. Contrarily, in OK CL wear, the
homeostasis of the ocular surface during the day is restored
every day.
On the other hand, it is necessary to take into account
the fact that all the participants in the Si-Hy group were
soft CL wearers before entering in the study while in the
OK group they were not, which could explain the fact that
discomfort and dryness symptoms reached slightly higher
scores (although not statistically significant) at the baseline
in the Si-Hy groups. It is possible that if all the participants
in the OK group were soft CL wearers, the symptomatology
reduction with the OK treatment would be bigger. Moreover,
as after sleeping with the OK CLs there is not enough tear
between theOKCLand the cornea, the participants in theOK
group were instructed to use artificial tears before removing
their CLs to avoid damaging the cornea when the subjects
removed the CLs. The artificial tears are present on the eye
only for a few seconds and it is not expected that they have
any effect over the dryness symptoms at the end of the
day. These differences are consistent with the real differences
existing in the clinic practice when these two types of CL are
fitted. Another factor that may have influence on the results
obtained is the fact that the Si-Hy subjects used their CLs
during the autumn and winter and the OK group started
the study during the spring and finished during the summer,
when the weather is hotter and dryer. This fact should be
favorable for better comfort with Si-Hy CLs than with OK
CLs.
Several studies have compared the comfort between OK
treatment and other CL wear modalities. Carracedo et al.
showed that discomfort and dryness symptoms were lower
with OK CLs compared to daily wear use of RGP CLs [33].
Lipson et al. compared hydrogel CLs in daily wear basis with
OK CLs in a group of 65 people who used 8-week SCLS
and 8-week OK CLs, worn in random order [54]. At the end
of the study, 65% preferred to continue using OK CLs, and
one of the reasons was to have less symptoms related with
the CLs. Additionally, there are a couple of studies where
the National Eye Institute Refractive Error Quality of Life
Instrument (NEI-RQL-42) was used, and the results showed
that the OK treatment is comparable to other modalities of
myopic correction in terms of discomfort [55, 56].
In summary, despite the fact that discomfort and dryness
symptoms at the end of the day are reduced in the Si-Hy
group, the reduction with the OKCLs is larger. In this regard,
the OK treatment could be an alternative to avoid drop-outs
among CLs wearers who suffer from dryness and discomfort
symptoms. However, more studies are needed to confirm that
dryness and discomfort symptoms are reduced in long term.
For further studies, it would be better that all the participants
in the study used both types of CLs, starting in random
order and changing the monthly replacement Si-Hy CL for
the new daily disposable CLs available in the market. Apart
from the subjective symptoms, it would be interesting trying
to measure the ocular dryness with objective tests such as
the osmolarity or taking more tear samples for analyzing DE
biomarkers.Moreover, it is unknown if the corneal sensitivity
is decreased while the OK CLs are worn. If the corneal
sensitivity is more reduced in the OK treatment than in
other CL modalities, this would explain, at least in part, the
symptoms reduction but might have some negative effects.
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